Skip to main content

Evolva launches new line for manufacturers of personal care products

| News

Evolva launches new line for manufacturers of personal care products


Evolva, a manufacturer of active ingredients based in Reinach in the canton of Basel-Landschaft, will be presenting its new product line for the personal care industry at the in-cosmetics trade fair in Barcelona on March 28-30. With the natural active ingredients resveratrol and L-arabinose, Evolva is targeting customers from this market segment for the first time.

Evolva's Headquarters in Reinach in the canton of Basel-Landschaft (img: Evolva)

Evolva, a biotechnology firm from the Basel Area, is launching a line of active ingredients for the personal care industry. Evolva will be presenting the two active ingredients resveratrol and L-arabinose at the in-cosmetics trade fair for manufacturers of ingredients and personal care products, which is taking place March 28-30 in Barcelona.

With its Responsible Care program, the ingredients manufacturer is looking to tap into the personal care industry for the first time, further details of which can be found in a press release. “The entire team is excited about introducing Evolva’s Responsible Care concept to the personal care industry, thereby addressing a new and interesting market segment for us”, comments Christian Wichert, CEO of Evolva, in the press release.

Balance of the skin’s microbiome

The concept is based around the two ingredients Juneo and Larally. The former is a natural resveratrol of the highest purity. The plant substance, which is produced through a fermentation process, has a rejuvenating and antioxidant effect. It is therefore an option for new body care products with a focus on areas such as oxidative stress, skin aging and hair protection, while also ensuring environmental compatibility.

The naturally occurring simple sugar Larally could play a key role in influencing and maintaining the balance of the skin’s microbiome, with scientific studies having empirically proven this effect. At present, a patent is pending for Larally. Both products enable manufacturers of personal care applications to create novel and sustainable consumer products capable of “delivering benefits perfectly in line with today’s mindful consumer expectations”.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

BOOM Summit in Basel accelerates health technology

The BOOM Summit at Messe Basel in April 2024 will be a completely new kind of healthcare conference. The first...
Read More

Investors stump up 3.7 million Swiss francs in Onena Medicines

Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of the biotech startup incubator BaseLaunch...
Read More

Do you have a question? We'd like to hear from you.